Table 5_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

Table 1_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

Table 4_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

Table 3_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

Table 6_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

Table 2_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

Single-Line scheme of Ajinde 62-node grid. by Zuhair Alaas (20868907)

“…<div><p>In distribution grids, excessive energy losses not only increase operational costs but also contribute to a larger environmental footprint due to inefficient resource utilization. …”

Correlation analysis of red blood cell-platelet ratio and coagulation indicators. by Jie Zhao (49409)

Subjects:

Univariate analysis of hospitalized patients. by Jie Zhao (49409)

Subjects:

The red blood cell-platelet ratio affects prognosis. by Jie Zhao (49409)

Subjects:

Red blood cell-platelet ratio and HR-restriction cube diagram during hospitalization. by Jie Zhao (49409)

Subjects:

Prognostic model for the red blood cell-platelet ratio and its trajectory categories during hospitalization. by Jie Zhao (49409)

Subjects:

Prognostic Impact of Red Blood Cell-Platelet Ratio Trajectory Categories after PSM. by Jie Zhao (49409)

Subjects:

Clinical baseline data. by Jie Zhao (49409)

Subjects:

Univariate analysis of ICU patients. by Jie Zhao (49409)

Subjects:

Prognostic model for the red blood cell-platelet ratio and its trajectory categories during ICU stay. by Jie Zhao (49409)

Subjects:

Impact of red blood cell-platelet ratio trajectories in the first four days before ICU admission on prognosis and clinical outcomes in the validation set. by Jie Zhao (49409)

Subjects:

Clinical baseline data after PSM. by Jie Zhao (49409)

Subjects:

Impact of red blood cell-platelet ratio trajectories on prognosis and clinical outcomes in the first four days before ICU admission in the training set. by Jie Zhao (49409)

Subjects:

International Classification of Diseases Codes. by Jie Zhao (49409)

Subjects: